» Articles » PMID: 17379451

Long-term Follow-up of Acoustic Schwannoma Radiosurgery with Marginal Tumor Doses of 12 to 13 Gy

Overview
Specialties Oncology
Radiology
Date 2007 Mar 24
PMID 17379451
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To define long-term tumor control and clinical outcomes of radiosurgery with marginal tumor doses of 12 to 13 Gy for unilateral acoustic schwannoma.

Methods And Materials: A total of 216 patients with previously untreated unilateral acoustic schwannoma underwent Gamma Knife radiosurgery between 1992 and 2000 with marginal tumor doses of 12 to 13 Gy (median, 13 Gy). Median follow-up was 5.7 years (maximum, 12 years; 41 patients with >8 years). Treatment volumes were 0.08-37.5 cm(3) (median, 1.3 cm(3)).

Results: The 10-year actuarial resection-free control rate was 98.3% +/- 1.0%. Three patients required tumor resection: 2 for tumor growth and 1 partial resection for an enlarging adjacent subarachnoid cyst. Among 121 hearing patients with >3 years of follow-up, crude hearing preservation rates were 71% for keeping the same Gardner-Robertson hearing level, 74% for serviceable hearing, and 95% for any testable hearing. For 25 of these patients with intracanalicular tumors, the respective rates for preserving the same Gardner-Robertson level, serviceable hearing, and testable hearing were 80%, 88%, and 96%. Ten-year actuarial rates for preserving the same Gardner-Robertson hearing levels, serviceable hearing, any testable hearing, and unchanged facial and trigeminal nerve function were 44.0% +/- 11.7%, 44.5% +/- 10.5%, 85.3% +/- 6.2%, 100%, and 94.9% +/- 1.8%, respectively.

Conclusions: Acoustic schwannoma radiosurgery with 12 to 13 Gy provides high rates of long-term tumor control and cranial nerve preservation after long-term follow-up.

Citing Articles

Characterization of facial nerve outcomes following radiosurgery for vestibular schwannoma: a meta-analysis.

Hovis G, Chandla A, Pandey A, Teton Z, Yang I Acta Neurochir (Wien). 2025; 167(1):30.

PMID: 39891778 PMC: 11787209. DOI: 10.1007/s00701-024-06405-3.


A retrospective cohort study of stereotactic radiosurgery for vestibular schwannomas: Comparison of two age groups (75 years or older vs. 65-74 years).

Watanabe S, Yamamoto M, Aiyama H, Sugii N, Matsuda M, Akutsu H Surg Neurol Int. 2024; 15:257.

PMID: 39108404 PMC: 11302593. DOI: 10.25259/SNI_148_2024.


Long-term hearing prognosis after vestibular schwannoma surgery with retrolabyrinthine approach.

Hosoya M, Nishiyama T, Shimanuki M, Ueno M, Ozawa H, Miyazaki H Eur Arch Otorhinolaryngol. 2024; 281(11):5699-5707.

PMID: 38977479 DOI: 10.1007/s00405-024-08786-8.


Hearing preservation surgery for vestibular schwannoma: a systematic review and meta-analysis.

Pontillo V, Foscolo V, Salonna F, Barbara F, Bozzi M, Messina R Acta Otorhinolaryngol Ital. 2024; 44(Suppl. 1):S86-S93.

PMID: 38745520 PMC: 11098544. DOI: 10.14639/0392-100X-suppl.1-44-2024-N2900.


Notch appearance as a novel radiological predictor of transient expansion and good outcome of expanding schwannoma after radiotherapy.

Yamazaki M, Takamatsu S, Iwata Y, Sakurai T, Taka M, Kobayashi S Discov Oncol. 2024; 15(1):79.

PMID: 38503989 PMC: 10951174. DOI: 10.1007/s12672-024-00936-y.